Mandate

Vinge has advised Stendörren in connection with a bond issue of up to SEK 1,000 million

August 14, 2017

Vinge has advised Stendörren Fastigheter AB (publ) (“Stendörren”) in connection with a bond issue of up to SEK 1,000 million senior unsecured floating rate bonds.

The bonds have a tenor of three years and a floating interest rate of three-months Stibor plus 4 per cent. ABG Sundal Collier AB and Swedbank have acted as financial advisors to Stendörren. Swedbank also acted as Issuing Agent.

The proceeds from the initial bond issue will primarily be used for refinancing of Stendörren’s outstanding SEK 750 million bonds, which will be made through a repurchase offer. The proceeds from the bond issue will also be used for acquisitions, investments and general corporate purposes. 

In accordance with the terms and conditions, the bonds are intended to be listed and admitted to trading on the corporate bond list at Nasdaq Stockholm shortly. As a result, the Company has prepared a prospectus which today has been approved by and registered with the Swedish Financial Supervisory Authority.

Vinges team consisted of Louise Brorsson Salomon, David Andersson, Sabina Börjesson, Josefine Larsson, André Isacson, Lionardo Ojeda and William Kåge

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026